Business Context and Reporting Period
Company: Eastman Kodak Company
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 1999
Business Overview: Kodak is engaged in developing, manufacturing, and marketing consumer, professional, health, and other imaging products and services. The company operates four primary segments: Consumer Imaging, Kodak Professional, Health Imaging, and Other Imaging. In 1999, the company continued its strategic shift toward digital imaging while maintaining its traditional film and paper businesses.
Key Financial Metrics
| Metric (in millions, except per share) | 1999 | 1998 |
|---|---|---|
| Sales | $14,089 | $13,406 |
| Gross Profit | $6,102 | $6,113 |
| Gross Margin | 43.3% | 45.6% |
| Earnings from Operations | $1,990 | $1,888 |
| Net Earnings | $1,392 | $1,390 |
| Basic EPS | $4.38 | $4.30 |
| Diluted EPS | $4.33 | $4.24 |
| Operating Cash Flow | $1,933 | $1,483 |
| Capital Additions | $1,127 | $1,108 |
| Short-term Borrowings | $1,163 | $1,518 |
| Long-term Borrowings | $936 | $504 |
| Working Capital (excl. borrowings) | $838 | $939 |
Material Changes vs. Prior Period
- Revenue Growth: Worldwide sales increased 5% to $14.089 billion, driven by growth in Health Imaging (up 39% due to the Imation acquisition), Consumer Imaging (up 3%), and Kodak Professional (up 4%). The Other Imaging segment declined 8% due to portfolio divestitures.
- Profitability: Net earnings remained flat at $1.392 billion compared to $1.390 billion in 1998. However, excluding special charges and credits, adjusted net earnings were $1.619 billion, representing a significant improvement over the prior year's adjusted earnings of $1.429 million.
- Margins: Overall gross profit margins decreased 2.3 percentage points to 43.3%, pressured by lower prices, increased goodwill amortization, and the lower-margin Imation acquisition. Excluding special charges, margins decreased only 0.4 percentage points.
- Digital Performance: Sales of digital and digitization products surged 46% to $2.333 billion, accounting for 17% of total sales. Digital losses improved by $146 million to $116 million.
- Restructuring: The company recorded a pre-tax restructuring charge of $350 million in 1999 related to manufacturing consolidation and workforce reductions, compared to no such charge in 1998 (though 1998 included a $132 million Office Imaging charge).
Guidance, Outlook, and Risks
- Restructuring Outlook: Management expects the 1999 restructuring program to yield $170 million in annual run-rate savings ($100 million in 2000, $70 million in 2001). The net cash cost of approximately $140 million is expected to be recovered in less than two years.
- Capital Spending: Capital spending in 2000 is expected to remain essentially unchanged from 1999 levels. Focus will shift from China manufacturing to digitization activities, IT, and facility renovations.
- Stock Repurchases: The company plans to repurchase shares in 2000 at a level sufficient to eliminate dilution from employee stock options, utilizing available cash and operating cash flow.
- Risks and Contingencies:
- Competition: Strong competition exists in both traditional and digital imaging markets globally.
- Raw Materials: Silver is an essential material for traditional film; the company uses forward contracts to hedge price risk.
- Environmental: Significant environmental remediation liabilities exist, with accrued costs of $124 million at year-end. Future expenditures are expected to increase.
- Year 2000: The company successfully transitioned to the Year 2000 without significant problems, though reliance on third-party suppliers remains a risk factor.
Investor Verification Checklist
- Adjusted Earnings Quality: Verify the sustainability of the $1.619 billion adjusted net earnings figure by reviewing the specific exclusions (restructuring charges, asset write-downs, and gains on asset sales).
- Digital Transition Costs: Assess the trajectory of digital product losses ($116 million in 1999) and the timeline for profitability given continued heavy investment.
- Restructuring Execution: Monitor the realization of the projected $170 million in annual cost savings and the completion of the 3,400 position eliminations by September 2000.
- Imation Integration: Evaluate the performance of the acquired Imation medical imaging business, which drove Health Imaging sales growth but lowered overall gross margins.
- Environmental Liabilities: Review Note 8 for updates on Superfund site costs and the Corrective Action Program at the Rochester facility, as these represent significant contingent liabilities.